In July 2023, the European Commission adopted its Implementing Decision on the adequate level of protection of personal data under the EU-US Data Privacy Framework (Adequacy Decision).
The manuscript “Target therapy for high-risk neuroblastoma treatment: integration of regulatory and scientific tools is needed” has just been published in the Frontiers in Medicine journal.
The European Medicines Agency has published a report on the experience gained in conducting studies with real-world data.
The Regulatory Science Network Netherlands Annual Workshop: Pharmaceutical legislation – Highway to innovation was held on 6 June in Utrecht
The European CRO Federation – EUCROF organizes the workshop “Essentials of Paediatric Clinical Research” that will take place on 12 September 2023 in Rome, Italy.
Coordinamento Thalassemici Regione Puglia is organising the conference “PUGLIA AND THALASSEMIA – Consapevolezza, Conoscenza, Cura” to be held on 10 June 2023 at the Hotel Hi-Bari, Bari – Italy.
The platform for healthcare professionals and patients with thalassaemia and sickle cell disease, called TIFLIX (Thalassaemia International Federation LIbrary eXtended) is now available!
The article “Off-label is not always off-evidence: authorising paediatric indications for old medicines” has been just published in The Lancet – Child & Adolescent Health!
The European Medicines Agency has published a report focused on the mid-term achievements of its Regulatory Science Strategy to 2025.
Viviana Giannuzzi, head of the research department at Fondazione Gianni Benzi, contributed as co-editor to the research topic “Reviews in: Regulatory Science” on the journal Frontiers in Medicine – Regulatory Science.
Recent posts in News